摘要
复发性呼吸道乳头状瘤是好发于呼吸道的良性肿瘤,手术为其主要治疗方式,但不能根治,常联合辅助药物治疗。目前认为西多福韦可以减少手术次数,延长手术间隔时间。本文从安全性、有效性等方面对西多福韦辅助治疗复发性呼吸道乳头状瘤的进展做一综述。
出处
《国际耳鼻咽喉头颈外科杂志》
2012年第5期270-272,共3页
International Journal of Otolaryngology-Head and Neck Surgery
基金
国家自然科学基金资助项目(8170900/H1302)
参考文献21
-
1Xiong X,Smith JL, Chen MS. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation. Antimicrob Agents Chemother, 1997,41(3): 594-599.
-
2Johnson JA,Gangemi JD. Selective inhibition of human papillomavirus-induced cell proliferation by (S) -1-[3-hydroxy-2-(phosphonylmethoxy) propyljcytosine. Antimicrob Agents Chemother, 1999, 43 (5):1198-1205.
-
3吴剑波,郑家润.西多福韦的药理、毒理及其在皮肤科的应用[J].国外医学(皮肤性病学分册),2005,31(1):3-5. 被引量:4
-
4Donne AJ, Hampson L,He XT, et al. Cidofovir induces an increase in levels of low-risk and high-risk HPV E6. Head Neck, 2009, 31 (7):893-901.
-
5Wemer RD, Lee JH, Hoffman HT, et al. Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol:Laryngol, 2005,114 (11): 836-839.
-
6Broekema FI, Dikkers FG. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol, 2008,265 (8):871-879.
-
7Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis, 2005 , 45 (5):804-817.
-
8Cundy KC. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet, 1999, 36(2): 127-143.
-
9Snoeck R, Wellens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovirf (S) -1- (3- hydroxy-2-phosphonylmethoxypropyl) cytosine] . J Med Virol, 1998,54 (3):219-225.
-
10Wiatrak BJ. Overview of recurrent respiratory papillomatosis. Curr Opin Otolaryngol Head Neck Surg, 2003,11 (6):433-441.
二级参考文献47
-
1Bienvenu B, Martinez F, Devergie A, et al. Topical use of cidofovir induced acute renal failure. Transplantation, 2002, 73:661 -662.?A?A?A
-
2Calista D, Regression of a cutaneous melanoma metastasis after intralesional cidofovir. Melanoma Res, 2003, 13:205 -206.
-
3Bienvenu B, Martinez F, Devergie A, et al. Topical use of cidofovir induced acute renal failure. Transplantation, 2002, 73:661 -662.
-
4Toro JR, Sanchez S, Turiansky G, et al. Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.Dermatol Clin, 2003, 21:301 - 309.?A
-
5Xiong X, Smith JL, Chen MS. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation.Antimicrob Agents Chemother, 1997, 41:594-599.?A
-
6Mendel DB, Barkhimer DB, Chen MS. Biochemical basis for increased susceptibility to cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity. Antimicrob Agents Chemother, 1995,39:2120 - 2122.?A
-
7Johnson JA, Gangemi JD. Selective inhibition of human papillomavirus-induced cell proliferation by (S) - 1 - [ 3 -hydroxy -2 - (phosphonylmethoxy) propyl ] cytosine. Antimicrob Agents Chemother,1999, 43:1198 - 1205.?A
-
8Andrei G, Snoeck R, Schols D, et al. Induction of apoptosis by cidofovir in human papillomavirus ( HPV ) - positive cells. Oncol Res,2000, 12:397-408.?A
-
9Liekens S, Neyts J, De Clercq E, et al. Inhibition of fibroblast growth factor - 2 - induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir. Cancer Res, 2001,61:5057 -5064.?A?A
-
10Cundy KC, Petty BG, Flaherty J, et al. Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother, 1995,39:1247-1252.?A
共引文献3
-
1刘剑峰,张瑞环,徐文方.西多夫韦的合成工艺改进[J].中国药物化学杂志,2007,17(1):41-43. 被引量:4
-
2翟岳玲,张东娜,窦媛媛,郭永建,王洪权.西多福韦凝胶剂的处方筛选[J].解放军药学学报,2015,31(6):521-522.
-
3房舒舒,张帅,曹国颖.核苷类抗病毒药物西多福韦的研究进展[J].中国药房,2016,27(21):3022-3024. 被引量:5
同被引文献12
-
1谢佳,谭国杰,于锋.手术联合抗病毒治疗儿童复发性喉乳头状瘤疗效分析[J].中国现代医药杂志,2012,14(7):1-3. 被引量:5
-
2雷文斌,刘其洪,柴丽萍,祝小林,王章锋,李清明,唐浩程,蒋爱云,文译辉,文卫平.成人喉乳头状瘤64例CO2激光黏膜下完整剥离术[J].中华耳鼻咽喉头颈外科杂志,2016,51(10):727-732. 被引量:8
-
3罗红艳,胡海燕,张良,廖骏华,程建红,王燕,韦懿.高渗盐水联合干扰素雾化吸入治疗婴幼儿毛细支气管炎的疗效及其对免疫功能的影响[J].儿科药学杂志,2017,28(1):11-15. 被引量:10
-
4韦舟雄,何江,吴铖林,张武宁,李永湘,林智强,黄坚成,毛海燕,阮开安,钟辉,姚清文.显微喉镜下CO_2激光手术治疗复发性小儿喉乳头状瘤临床疗效[J].右江民族医学院学报,2017,39(3):201-202. 被引量:4
-
5张婷婷,仲金秋,曹玉珠,吴佳伟,陈文星,王爱云,陆茵.干扰素抗肿瘤机制及其治疗肿瘤的研究进展[J].中国药理学通报,2017,33(9):1195-1199. 被引量:9
-
6李英丽,吴明哲,柴晓明,许晶.幼年型喉乳头状瘤支气管及肺内播散的CT表现[J].临床耳鼻咽喉头颈外科杂志,2018,32(10):767-769. 被引量:3
-
7倪荣华,张成一,林志宏.支撑喉镜下低温等离子射频术治疗成人喉乳头状瘤的临床疗效观察[J].中国基层医药,2018,25(21):2811-2814. 被引量:2
-
8戴俊,怀德,汪守峰,王海旭,宋红毛.支撑喉镜下CO_2激光手术治疗喉乳头状瘤[J].中国耳鼻咽喉头颈外科,2015,22(3):142-144. 被引量:9
-
9向磊,郑玉晗,邓绍光.干扰素治疗复发性小儿喉乳头状瘤的临床效果[J].中国继续医学教育,2019,11(13):132-134. 被引量:2
-
10龙松良,赵斯君,黄敏,李赟,罗欣友.直达喉镜下肿瘤切除手术联合干扰素治疗儿童喉乳头状瘤病的疗效[J].儿科药学杂志,2019,25(11):5-8. 被引量:2
-
1王雨,张天宇,戴培东.西多福韦治疗喉乳头状瘤[J].国际耳鼻咽喉头颈外科杂志,2011,35(5):293-295.
-
2张春丽.西多福韦抑制宫颈癌Siha细胞增殖作用的研究[J].中国全科医学,2009,12(22):2021-2024. 被引量:5
-
3谢佳,谭国杰,于锋.手术联合抗病毒治疗儿童复发性喉乳头状瘤疗效分析[J].中国现代医药杂志,2012,14(7):1-3. 被引量:5
-
4赵燕玲.复发性呼吸道乳头状瘤研究进展[J].国外医学(耳鼻咽喉科学分册),2002,26(1):33-37. 被引量:2
-
5崔彦儒,王军.幼儿复发性呼吸道乳头状瘤药物治疗[J].国际耳鼻咽喉头颈外科杂志,2007,31(1):46-49.
-
6张志勇,张雪峰.鼻腔及鼻窦内翻性乳头状瘤2例[J].包头医学院学报,2002,18(3):240-240.
-
7郑朝晖,邱恩惠,陈晓芳,洪育明,梁振源.氟尿嘧啶联合西多福韦术后治疗成人喉乳头状瘤临床疗效观察[J].新乡医学院学报,2014,31(12):1028-1029. 被引量:2
-
8庄佩耘,张天宇,周莉,沈雁,蒋家琪.复发性呼吸道乳头状瘤治疗新进展[J].中华耳鼻咽喉头颈外科杂志,2007,42(12):956-958. 被引量:3
-
9林尚泽.经皮注射Cidofovir治疗喉乳头状瘤病[J].国外医学(耳鼻咽喉科学分册),2003,27(5):302-302.
-
10康尧杰,刘世喜.复发性呼吸道乳头状瘤辅助治疗新进展[J].中国眼耳鼻喉科杂志,2015,15(4):294-297. 被引量:2